Jerphason Ongayo Mecha

Has grant

Biostatistician

Kenya Medical Research Institute
Country flagNo Info

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Enhancing Adherence and Completion of the Three-Month Isoniazid with Rifapentine (3HP) Tuberculosis Preventive Therapy Regimen Through Biomarker-Guided Adherence Counselling (ACT-TPT)

Open Date: 2025-12-01

Close Date: 2030-12-01

Grant: Close

Factors Affecting the Implementation of Short-Course Tuberculosis Preventive Therapy Regimens(3HP) among People Living with HIV (PLHIV) in Kisumu County, Kenya: A Qualitative Study

Open Date: 2024-12-01

Close Date: 2025-12-01

Grant: Close

Systems Analysis and Improvement Approach to Optimize the Tuberculosis Preventive Therapy Cascade (SAIA-TPT)

Open Date: 2023-11-01

Close Date: 2026-02-01

Grant: Close

Factors affecting uptake, adherence and outcomes of newer recommended short-regimen tuberculosis preventive therapy among people living with HIV in Kenya

Open Date: 2023-01-01

Close Date: 2024-12-01

Articles (11)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Background: The effect of maternal HIV on infant Mycobacterium tuberculosis (Mtb) infection risk is not well-characterized. Methods: Pregnant women with/without HIV and their infants were enrolled in a longitudinal cohort in Kenya. Mothers had interferon gamma-release assays (QFT-Plus) and tuberculin skin tests (TST) at enrollment in pregnancy; children underwent TST at 12 and 24 months of age. We estimated the incidence and correlates of infant TST-positivity using Cox proportional hazards regression. Results: Among 322 infants, 170 (53%) were HIV-exposed and 152 (47%) were HIV-unexposed. Median enrollment age was 6.6 weeks [interquartile range (IQR): 6.1–10.0]; most received Bacillus Calmette-Guerin (320, 99%). Thirty-nine (12%) mothers were TST-positive; 102 (32%) were QFT-Plus-positive. Among HIV-exposed infants, 154 (95%) received antiretrovirals for HIV prevention and 141 (83%) of their mothers ever received isoniazid preventive therapy (IPT). Cumulative 24-month infant Mtb infection incidence was 3.6/100 person-years (PY) [95% confidence interval (CI): 2.4–5.5/100 PY]; 5.4/100 PY in HIV-exposed infants (10%, 17/170) versus 1.7/100 PY in HIV-unexposed infants (3.3%, 5/152) [hazard ratio (HR): 3.1 (95% CI: 1.2–8.5)]. More TST conversions occurred in the first versus second year of life [5.8 vs. 2.0/100 PY; HR: 2.9 (95% CI: 1.0–10.1)]. Infant TST-positivity was associated with maternal TST-positivity [HR: 2.9 (95% CI: 1.1–7.4)], but not QFT-Plus-positivity. Among HIV-exposed children, Mtb infection incidence was similar regardless of maternal IPT. Conclusions: Mtb infection incidence (by TST) by 24 months of age was ~3-fold higher among HIV-exposed children, despite high maternal IPT uptake. Overall, more TST conversions occurred in the first 12 months compared to 12–24 months of age, similar in both HIV-exposed and HIV-unexposed children.

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

Jeremy Boss

Professor and Chair

Emory University School of Medicine

UNITED STATES
View details

Ashenafi Cherkos

Assistant Professor

University of North Texas Health Science Center

UNITED STATES
View details

Joy Githua

Kenya Medical Research Institute

View details

Lilian N Njagi

Senior Clinical Research Scientist

Kenya Medical Research Institute

View details

Thomas Hawn

Professor

University of Washington

UNITED STATES
View details

Marianne AB van der Sande

Institute of Tropical Medicine Antwerp

BELGIUM
View details

David Horne

Professor

University of Washington

UNITED STATES
View details

Nuttada Panpradist

Assistant Professor

University of Texas at Austin

UNITED STATES
View details

Grace John-Stewart

Professor

University of Washington

UNITED STATES
View details

Sylvia M. LaCourse

University of Washington

UNITED STATES
View details